India  

Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV Congress

Business Wire Thursday, 12 September 2019
Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV CongressLEXINGTON, Mass.--(BUSINESS WIRE)--$CNCE #CNCE--Concert will present CTP-543 Phase 2 results in alopecia areata during the late breaking news session at the EADV Annual Congress in October 2019.
0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this